Detalhe da pesquisa
1.
BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Genet Mol Biol
; 39(2): 223-31, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27303907
2.
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines.
Invest New Drugs
; 32(5): 783-94, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24838627
3.
Triple negative breast cancer: A thorough review of biomarkers.
Crit Rev Oncol Hematol
; 145: 102855, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31927455
4.
miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Pancreas
; 45(1): 84-92, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26262588
5.
H4K12 and H3K18 Acetylation Associates With Poor Prognosis in Pancreatic Cancer.
Appl Immunohistochem Mol Morphol
; 24(5): 337-44, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26067135
6.
Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.
World J Gastroenterol
; 17(6): 766-73, 2011 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21390147
7.
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.
Hered Cancer Clin Pract
; 9: 12, 2011 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22185575